Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS
about
Development, maintenance and disruption of the blood-brain barrierDietary supplementations as neuroprotective therapies: focus on NT-020 diet benefits in a rat model of strokeNovel molecular biomarkers at the blood-brain barrier in ALSBlood-CNS Barrier Impairment in ALS patients versus an animal modelChronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALSAquaporins in the Spinal CordThe blood-spinal cord barrier: morphology and clinical implicationsFlavin-containing monooxygenase mRNA levels are up-regulated in als brain areas in SOD1-mutant miceReduction of circulating endothelial cells in peripheral blood of ALS patientsNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersT₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.Inflammation in ALS and SMA: sorting out the good from the evil.Blood-brain barrier impairment in an animal model of MPS III BIdentification and characterization of Nanobodies targeting the EphA4 receptor.ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration.Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).Apelin deficiency accelerates the progression of amyotrophic lateral sclerosis.Possible association between expression of chemokine receptor-2 (CCR2) and amyotrophic lateral sclerosis (ALS) patients of North India.The blood-brain barrier in health and disease.Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations.CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosisPotential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice.Effects of peripheral inflammation on the blood-spinal cord barrier.Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis.Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.Neuroprotective and Angiogenic Effects of Bone Marrow Transplantation Combined With Granulocyte Colony-Stimulating Factor in a Mouse Model of Amyotrophic Lateral Sclerosis.Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytesDysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease.Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice.ALS and oxidative stress: the neurovascular scenarioActivated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cellsImmunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis.Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice.Degeneration and repair in central nervous system disease.The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells.Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.Cerebrovascular disorders: molecular insights and therapeutic opportunities.Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis.Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis?
P2860
Q26829668-10BBD901-AE2A-494C-810D-90B5C2765380Q26991784-C4678239-B829-46A1-9BD6-BA710DB8A968Q27004431-F075BA21-24A7-4226-826F-3C12275CC370Q27026792-0AAE8DB7-40DD-4561-B382-BD9731724A14Q27303112-2CE6F11D-CAB2-47C8-B5CD-87B30CBB89B9Q28066783-6AE9387C-C275-4422-A1E7-40B39B56ADE5Q28240807-9A9397D6-DA7A-4E81-A367-F0F8A75BD229Q28298572-3C02E3D9-8210-4A5D-8F55-50A6FB6D7031Q28752226-B505C13D-58FE-4F7D-B7D5-45DFB7B17000Q29615839-FDAD0729-7C2D-4212-ACB2-55F71A9C9381Q33581148-BD7B1494-61C8-47E4-A8B5-B8536C54043AQ33664711-66F0FD37-C2FC-4399-B404-9570D4B714ADQ33847821-B8479A4D-35C7-4DE3-94D9-56344FFE1063Q33882055-6A01DE2E-C3DF-4290-87B9-B2B2A3829164Q33954016-35DB014D-F30A-464D-8C08-C5B87565AF48Q34005426-6E3C1316-F4B7-4860-A82B-2837968764A9Q34009735-725C9248-5247-4ADD-A5E6-130A971B3B92Q34299611-93D3B08D-457A-4ED9-A747-4AA06BDAB800Q34320420-4DB5915B-5FD1-4864-8244-A7288D501502Q34336785-64FA39F6-291C-4D33-8425-D20D748D8622Q34500059-FC9C1B0E-C09F-47D1-98F7-353473B17A42Q35779264-363D978A-6835-43BA-850D-1FF27CC10238Q35800499-46E01A4C-45A2-45FF-BDBF-9423C34A8786Q36123303-8845A96C-6608-4D35-9A12-E81EDC614EF9Q36246992-85D954DC-A763-468E-9566-9EF955BDCAAAQ36503292-DA572E3B-4C8E-4CEA-90AA-D8A2D92DE512Q36680605-8C21AFB6-3719-4CF2-99E7-3CD789684821Q36953721-08B229E7-D868-4426-BB2F-7A9C3E694C8DQ37017486-BA72D91C-19E3-4D3B-ACA1-06C7C84A5497Q37290026-B7ABCF7B-C005-4DE3-9D2B-23A0E8F00623Q37400451-BE86F502-8EA7-4303-97C0-BDACAE2B70DEQ37403120-CEFB916E-C880-4D87-9004-733B39A0D6A8Q37563994-5802BD2F-8733-4E12-B88E-E9C1068AC11DQ37659809-B4F2FDE0-D722-4DB6-92AD-BB3DC3A8F39FQ37701373-035DFFC4-254B-48FD-ADA2-534EDEB5C5BFQ37795969-63D561EE-7931-4AEB-8F2D-783D71764676Q37890058-05242FDC-B320-4628-B1F6-9DE48752B719Q37949813-DA0A7697-A509-4E56-ABEF-D6FF9A80E922Q37960903-5F3E9248-4AC9-486C-A5E8-9008DC029DA4Q38006693-254B0993-50BB-4050-9C4A-6B350C77A66E
P2860
Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@ast
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@en
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@en-gb
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@nl
type
label
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@ast
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@en
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@en-gb
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@nl
prefLabel
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@ast
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@en
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@en-gb
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@nl
P2093
P2860
P3181
P1433
P1476
Evidence of compromised blood- ...... tomatic SOD1 mice modeling ALS
@en
P2093
Huntington Potter
Irina Kolomey
Paul R Sanberg
Samuel Saporta
Steven P Bennett
Svitlana Garbuzova-Davis
P2860
P3181
P356
10.1371/JOURNAL.PONE.0001205
P407
P577
2007-01-01T00:00:00Z